RAD51 is an indispensable homologous recombination protein, necessary for strand invasion and crossing over. It has recently been designated as a Fanconi anemia (FA) gene, following the discovery of two patients carrying dominant-negative mutations. FA is a hereditary DNA-repair disorder characterized by various congenital abnormalities, progressive bone marrow failure, and cancer predisposition. In this report, we describe a viable vertebrate model of RAD51 loss. Zebrafish rad51 loss-of-function mutants developed key features of FA, including hypocellular kidney marrow, sensitivity to cross-linking agents, and decreased size. We show that some of these symptoms stem from both decreased proliferation and increased apoptosis of embryonic hematopoietic stem and progenitor cells. Comutation of p53 was able to rescue the hematopoietic defects seen in the single mutants, but led to tumor development. We further demonstrate that prolonged inflammatory stress can exacerbate the hematological impairment, leading to an additional decrease in kidney marrow cell numbers. These findings strengthen the assignment of RAD51 as a Fanconi gene and provide more evidence for the notion that aberrant p53 signaling during embryogenesis leads to the hematological defects seen later in life in FA. Further research on this zebrafish FA model will lead to a deeper understanding of the molecular basis of bone marrow failure in FA and the cellular role of RAD51. 
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Fanconi anemia | stem cells | hematopoiesis | cytokine effects | inflammation F anconi anemia (FA) is a hereditary DNA-repair disorder characterized by various congenital abnormalities, progressive bone marrow failure (BMF), and cancer predisposition (1) . It is caused by mutations in one of 21 genes in the FA pathway (2, 3) (www2.rockefeller.edu/fanconi/). The FA pathway has been shown to be the major route for the removal of interstrand crosslinks (ICL): DNA lesions that prevent replication and transcription by inhibiting DNA strand separation (4, 5) . When the pathway is defective, these structures cannot be removed, potentially leading to cell death (6) . Indeed, sensitivity to cross-linking agents, such as mitomycin C (MMC), is an absolute diagnostic criterion of FA (7) .
Although FA is characterized by remarkable phenotypic heterogeneity, FA patients usually succumb to the depletion of hematopoietic stem and progenitor cells (HSPCs) in their BM, leading to pancytopenia and complete BMF. Therefore, BM transplantation is the only modality that offers a potential cure of hematopoietic defects but is itself associated with considerable morbidity (8, 9) . Interestingly, a decrease in HSPCs (CD34 + cells) is already apparent in FA infants even before the first hematological symptoms appear (10) . This finding led to the hypothesis that FA originates from defects during the formation of the initial HSPC pool, presumably because of an overactive p53/p21 response and cell cycle arrest (10) . In agreement with this, FA mice have considerably smaller fetal livers than their healthy siblings (11) . It remains unclear, however, at which stage during embryonic development these defects appear and how perturbation in the production of embryonic HSPCs relates to the phenotype seen in adulthood.
Because of the role FA genes play in the repair of ICLs, DNA damaging agents causing ICLs have been proposed as a major cause of BMF, with small aldehydes being the most likely candidates. Comutation of genes in the FA pathway and aldehyde metabolizing genes (Aldh2 and Adh5) resulted in significant reduction of HSPCs and BMF in double-mutant mice (12) (13) (14) (15) (16) . In addition, FA patients lacking ALDH2 show a more severe phenotype (17, 18) . Apart from their hypersensitivity to crosslinking agents, FA cells also react excessively to proapoptotic cytokines, such as IFN-γ and TNF-α (19) (20) (21) (22) (23) (24) . However, the role of cytokines in the etiology of BMF remains controversial (25) (26) (27) (28) .
In the last 2 y, a novel FA subtype associated with dominantnegative mutations in RAD51 has been reported, leading to the designation of RAD51 as FANCR (29) (30) (31) . It has been shown to be involved in protecting broken down replication forks from excess processing by nucleases, linking the FA pathway with RAD51/ BRCA2 (29, 32) . In vivo studies of Rad51 have previously been very difficult, as mice lacking the protein invariably die during early embryogenesis (33, 34) .
In this study, we characterized a viable vertebrate model of Rad51 loss. Indeed, our zebrafish rad51 loss-of-function mutant recapitulates many congenital and hematological features of FA. We provide in vivo evidence that decreased HSPC numbers during embryonic development directly lead to the later BM defects in FA. Finally, we show that rad51 mutants do not overproduce inflammatory cytokines, but are more sensitive to them and that prolonged inflammatory stress can further reduce marrow cellularity.
Significance
The homologous recombination protein RAD51 has been extensively studied in prokaryotes and lower eukaryotes. However, there is a significant lack of knowledge of the role of this protein and its regulation in an in vivo context in vertebrates. Here we report the first viable vertebrate mutant model of rad51 in zebrafish. These mutant fish enabled us to confirm the recently discovered role of RAD51 in Fanconi anemia pathogenesis. We report that p53-linked embryonic stem cell defects directly lead to hematological impairments later in life. Comutation of rad51 with p53 rescues the observed hematological defects, but predisposes the fish to early tumor development. The application of this model opens new possibilities to advance Fanconi anemia drug discovery.
Results
The rad51
sa23805 Allele Leads to Complete Loss of Functional Rad51.
To study the function of Rad51 in hematopoiesis, we obtained fish carrying the rad51 sa23805 allele from the Sanger Institute Zebrafish Mutation Project (35) . The rad51 sa23805 allele has a C > T mutation at codon 203 in exon 7, which leads to a premature stop codon in the region of the RecA domain. In contrast to mice lacking Rad51, which invariably die during early development (33, 34) , fish carrying homozygous copies of the rad51 sa23805 (referred to as rad51 −/− for brevity in the text) survive to adulthood. However, all surviving adults undergo sex reversal and are infertile males, lacking mature spermatozoa in the testes (SI Appendix, Fig. S1 ).
To ensure complete loss-of-function of the rad51 sa23805 allele, we carried out a Western blot on testicular tissue, because Rad51 is highly expressed in germ cells in zebrafish and other species (36, 37) . This approach confirmed that the full-length protein is lost in rad51 −/− fish (Fig. 1A) . However, immunostaining for Rad51 at the one-cell stage embryos (i.e., before maternal to zygotic transition) (38) showed diffuse staining in the cytoplasm of all embryos resulting from a rad51 +/− in-cross (Fig. 1B) . This finding suggested that rad51 −/− embryos have maternally derived Rad51. Because of the early embryonic lethality of murine Rad51 mutants (33, 34) , we decided to look at the functional redundancy between rad51 and its paralogues. To do this, we knocked out rad51l1, the fish ortholog of the human RAD51B gene using CRISPR. Initially, we raised 204 embryos resulting from a rad51
+/− in-cross to adulthood. However, of these none were double mutants, even though 12.75 would be expected from Mendelian inheritance. We repeated the same cross and collected embryos at 4 d postfertilization (dpf). Again, 0 of 44 embryos were double mutants, even though 2.75 would have been expected. Finally, we repeated the cross and genotyped at 6 h postfertilization (hpf; the earliest point the genotyping works reliably). Of 47 embryos, none were double mutants. This early embryonic synthetic lethality of comutation indicates that rad51 and rad51l1 have at least some redundant functionality.
Lack of Rad51 in Embryos Leads to Increased DNA Damage Sensitivity.
Rad51 is essential for the repair of ICLs and double-stranded breaks via homologous recombination (HR). In ICL repair, it plays a role in both HR-linked processes, as well as HR-independent steps (29) (30) (31) . To investigate the role of Rad51 in the repair of ICLs, we treated embryos resulting from an in-cross of rad51 +/− parents with the cross-linking agents diepoxybutane (DEB) and MMC, as well as the topoisomerase I inhibitor camptothecin (CPT) and the poly(ADP-ribose) polymerase (PARP)-1 inhibitor 1,5-isoquinolinediol (DiQ). After treatment, the tails of the embryos were used for chromosome spreads, whereas the heads were kept for genotyping. The spreads revealed that DEB induced defects characteristic for FA, including breaks and radial structures (Fig. 1C) . MMC induced many of the same features, but also led to considerably more premature chromatid separation events (SI Appendix, Fig. S2A ). Similarly, CPT induced high levels of chromosome breaks, but few radial structures (SI Appendix, Fig. S2B ). DiQ, on the other hand, was embryonic-lethal at higher concentration (100 μM), but at lower levels (10 μM) induced just a few breaks in both WT and mutant embryos (SI Appendix, Fig. S2C ).
We also examined the role of Rad51 in the repair of other forms of double-stranded breaks not involving cross-linking agents. For this, we irradiated 24-h-old embryos from an in-cross of rad51 +/− parents with γ-radiation and examined them at 48 hpf. The irradiated embryos were then blindly imaged, scored, and genotyped. The rad51 −/− embryos developed small eyes and heads in response to radiation ( Fig. 1 D, i ). This phenotype was limited to the rad51 −/− embryos ( Fig. 1 D, ii) , showing that they are more sensitive to irradiation than WT siblings. In addition, pH2AX (a marker of double-stranded breaks) immunostaining of nonirradiated embryos revealed extensive DNA damage in embryos lacking Rad51 in comparison with their WT siblings (Fig. 1E ). Taken together, these data suggest that rad51 −/− embryos are hypersensitive to DNA damage.
Finally, we considered the role of nonhomologous end-joining (NHEJ) in the survival of our mutant fish. To do that, we treated an in-cross of rad51 +/− parents with a range of different concentrations of SCR-7, a DNA ligase IV inhibitor, and scored the embryos at 24 hpf (SI Appendix, Fig. S3 ). At the lowest concentration, embryos were completely unaffected, whereas at the higher concentration all embryos died. At no concentration were the mutant embryos more sensitive than their WT siblings (SI Appendix, Fig. S3 ), indicating that NHEJ is dispensable for the survival of rad51 −/− embryos.
Rad51 Mutants Recapitulate Many Congenital and Hematological
Features of FA. RAD51 mutations were recently linked to FA in humans in two case reports (29, 30) . Therefore, we examined the rad51 mutant fish for congenital and hematological features associated with FA. A common congenital symptom of FA is decreased height (1). On account of that, we measured the body length of fish with and without rad51 mutation throughout development. Although embryonic development was not affected by the mutation, the size of rad51 −/− fish was decreased compared with their WT siblings, starting from around 23 dpf (SI Appendix, Fig. S4A ). The size reduction during the larval period was maintained to adulthood with rad51 mutant fish being on average 10% shorter than their WT siblings (SI Appendix, Fig. S4 B and C). In addition, rad51 −/− embryos and larvae developed microphthalmia, another distinct feature of FA patients (SI Appendix, Fig. S5 ).
To assess whether loss of rad51 affects adult hematopoiesis, we inspected the kidney marrow (WKM) of zebrafish, which is analogous to BM in mammals. Unlike in mammals, there is only one kidney in zebrafish, which is the only site of adult hematopoiesis. Importantly, there is no space restriction of the marrow by the rigid bone, as kidney tissue is very spongy and flexible. We first obtained several H&E-stained histological sections each of the kidney of four WT and mutant fish, ranging between 4 and 8 mo of age. Representative sections showed no noticeable qualitative differences between rad51 +/+ and rad51 −/− fish ( Fig. 2A) . However, even though the morphology appeared normal, kidney size and cell number were considerably (∼50%) decreased in rad51 −/− fish (Fig.  2B) . The kidney cellularity of rad51 −/− fish gradually decreased with aging, but at the same rate as in WT fish ( Fig. 2 B , ii), suggesting that the mutants established steady-state hematopoiesis despite displaying kidney hypocellularity. Although rad51 mutants did not develop cytopenia in the peripheral blood (PB) (Fig. 2C ), they did accumulate macrocytic erythrocytes in the PB (Fig. 2D) , suggesting a gradual worsening of the phenotype over time.
Rad51
−/− Fish Show a Hyperproliferative Phenotype in the WKM. The number of cells in the WKM is determined by the balance between their proliferation and apoptosis rate, as well as their migration to the PB. To test whether the decrease in kidney cell numbers in rad51 mutants was a result of apoptosis, we carried out an Annexin V-propodium iodide (AV-PI) staining assay on kidney tissue ( Fig.  3A and SI Appendix, Fig. S6 A and B) . We observed no statistically significant difference between rad51 +/+ and rad51 −/− fish, excluding apoptosis as an initial cause for the decrease in cell numbers in the kidney. Therefore, we next focused on the proliferation of the kidney marrow cells.
The standard assay for assessing cell proliferation rates is the incorporation of BrdU into the DNA. To follow the kinetics of BrdU incorporation and dilution via division or migration to the circulation, we measured BrdU labeling at several time points postinjection (Fig. 3B) . Because erythrocytes are nucleated in zebrafish, our analysis was not limited only to leukocytes and allowed us to robustly assess changes in the WKM as well as in the PB. The initial number of BrdU + cells in the WKM was twofold higher in rad51 −/− fish compared with the control (Fig. 3 C, i and SI Appendix, Fig. S6F ), suggesting an increased proliferation rate in the mutant. This was followed by a fast dilution of the BrdU label over 2 wk, because of the increased cell division of mutant HSPCs (Fig. 3 C, i ). In line with this finding, the initial number of BrdU + cells in the PB was higher in rad51 −/− fish compared with WT siblings (Fig. 3  C, ii) , but then plateaued faster because of the dilution of the label in the kidney (Fig. 3 C, ii) .
To show that blood, rather than other cells in the WKM, are proliferating, we generated mutants in various transgenic backgrounds. The rad51 −/− Tg(gata1a:EGFP) line (39) was used to assess the erythrocytic lineage, including erythrocytic progenitors. The rad51 −/− Tg(cd41/itga2b:EGFP) (40) line was used to detect thrombocytic progenitors, which are labeled in the cd41:EGFP dim subpopulation (41) . Consistent with the BrdU incorporation experiments, we saw an increase in newly made gata1:EGFP + erythrocytes in the kidney (Fig. 3D and SI Appendix, Fig. S6C ), as well as an increase in cd41:EGFP dim thrombocytic progenitors ( Fig.  3E and SI Appendix, Fig. S6D) .
Together, this evidence shows that loss of rad51 leads to a hyperproliferation of HSPCs, possibly as a compensatory mechanism to prevent cytopenia in the PB. However, the lowered cellularity of the kidney in adult rad51 −/− fish cannot be explained by this finding, suggesting that the kidney cytopenia stems from an early, possibly embryonic HSPC defect. in which the HSCs expand greatly, akin to the mammalian fetal liver (42) .
To assess the underlying cause of the decreased number of cells in the adult kidney of FA fish, we focused on embryonic hematopoiesis. To this end, we used whole-mount in situ hybridization (ISH) using a cmyb-specific probe, which labels HSPCs. Indeed, at 2 dpf, rad51 −/− embryos had a decreased number of HSPCs compared with the WT embryos from the same clutch (Fig. 4A) . At 4 dpf, the difference in the number of HSPCs in the CHT of rad51 −/− and WT embryos was further exacerbated (Fig. 4B) . Following up on that finding, we carried out a BrdU incorporation assay on the tail tissue of 2-dpf embryos, which showed that the proliferation rate in the tail of rad51 −/− embryos was about half that of rad51 +/+ embryos (Fig. 4C) . Although not statistically significant, this trend was still apparent in the CHT at 4 dpf (Fig. 4D) .
In addition to proliferation, we also investigated apoptosis at 2 dpf by carrying out a TUNEL assay on several crosses of rad51 heterozygotes. This process revealed a twofold increase in apoptosis in the CHT in mutants compared with WT embryos (Fig. 4 E  and F) . Taken together, our data imply that the cytopenia in the adult kidney is caused by an increase apoptosis of HSPCs, as well as reduced proliferation during early embryogenesis, mainly before 4 dpf.
The HSPC Defects in rad51 −/− Fish Are Mediated via p53. The defects seen in FA have recently been linked to an aggravated p53 response (10) . To focus on the role of p53 in the HSPC defect, we generated a zebrafish line carrying mutations in both rad51 and p53. This double mutation was able to rescue the number of HSPCs in the CHT of 4-dpf embryos ( Fig. 5A and SI Appendix, Table S3 ). Importantly, the number of cells in the adult WKM of p53 −/− rad51 −/− fish reached WT levels by 4 m postfertilization (mpf) (Fig. 5B) . Along with the rescued marrow cellularity, there was no difference in the proliferation of cells in the WKM of WT and double-mutant fish at 4 mpf, as shown by a BrdU incorporation assay (Fig. 5C ).
We also examined the congenital phenotypes in the double mutants. The sex reversal seen in rad51 single mutants was corrected (SI Appendix, Fig. S7 A-C) , but the size defect was not (SI Appendix, Fig. S7D ). However, neither female, nor male double mutants were fertile (SI Appendix, Fig. S7 A-C) . Taken together, our data suggest that the marrow hypocellularity in adult fish was not because of the smaller size of rad51 mutant, meaning that these two phenotypes are uncoupled. Instead, we observed a high correlation between the number of HSPCs generated early during embryonic development and the kidney marrow cellularity in adulthood. Therefore, the rescue in the embryonic definitive hematopoiesis can revert all defects observed in adult hematopoiesis in rad51 mutants.
Finally, the tumor incidence of the double mutants was 30%, with the first tumors developing from 5 mpf [5 mo earlier than reported for p53 single mutants (43) ]. The tumors resembled malignant peripheral nerve sheath tumors (MPNSTs), (SI Appendix, Fig. S7 E and F) , which is the most common type of malignancy in p53 −/− fish (43) . None of the other fish (i.e., WT, rad51 mutants, and heterozygotes) developed any kind of noticeable tumor, including the oldest 13-mpf rad51 −/− fish. An aberrant inflammatory response has been postulated to be one of the potential causes of the BMF in FA. This is thought to be a result of increased expression of inflammatory cytokines in FA patients and an excess apoptosis of HSPCs in response to these factors. To test this hypothesis, we developed a zebrafish model of prolonged inflammatory stress. Over a period of 4 wk, we injected rad51 −/− and WT fish with the immunostimulant polyinosinic:polycytidylic acid (pI:pC) and assessed changes in the kidney cellularity, lineage output, and the expression of genes associated with inflammation (Fig. 6A) .
PI:pC resembles double-stranded RNA and is known to induce the expression of proinflammatory cytokines, such as TNF-α (44) and IL-1 (45) . Therefore, it has been considered to accurately mimic viral infection (45) in murine and fish models (44) (45) (46) (47) . Indeed, a single intraperitoneal injection of pI:pC in zebrafish induced robust inflammatory response just 6 h postinjection (SI Appendix, Fig. S8A ). Mutants did not express more inflammatory cytokines when unchallenged (SI Appendix, Fig. S8B ). Importantly, the prolonged exposure of adult WT fish to pI:pC resulted in a twofold increased production of monocytes (Fig. 6B ) but did not overtly affected kidney marrow cellularity or cell viability ( Fig. 6 C and D) . In addition, we observed clear up-regulation of monocyte-specific genes (SI Appendix, Fig. S8C ). The skew toward monocyte production in turn decreased the erythrocyte output and to a lesser extent other lineages. In contrast, repeated pI:pC injections of rad51 −/− fish led to no significant change in the number of produced monocytes (Fig. 6B) and an ∼25% decrease in the total number of cells in the kidney (Fig. 6C) . As in the WT fish, the prolonged inflammation decreased the number of erythrocytes in the kidney marrow of rad51 −/− fish, thus possibly contributing to the overall reduction in kidney cellularity. This was mediated by a normalization of proliferation rates in the kidneys of pI:pC-injected mutant fish ( Fig. 6E and SI Appendix, Fig. S8D) . Therefore, the prolonged inflammatory stress can lead to severe marrow defects in our rad51 −/− zebrafish FA model not only in terms of the lineage output, but also by affecting the total marrow cellularity.
Interestingly, the unchallenged rad51 mutants down-regulated p53, but showed an exaggerated reaction in p53 expression to repeated inflammatory stress (Fig. 6 F, i) . Fitting with this observation, p21 expression followed a similar trend in gene expression in noninjected and pI:pC-injected mutants (Fig. 6 F, ii) . DNA damage induced by small aldehydes has been proposed as a major cause of exhaustion of the HSCs in the BM of FA patients (12) (13) (14) (15) (16) (17) (18) . To examine the sensitivity of rad51 mutants to acetaldehyde, we exposed them to acetaldehyde-induced stress over a period of 4 wk (SI Appendix, Fig. S9A ). Our analysis revealed an increase in WKM cellularity in WT fish in all blood cell types (SI Appendix, Fig. S9 B and C) upon acetaldehyde injections, whereas rad51 mutant cell numbers were unaffected. The viability of WKM cells was decreased to a similar extent in both WT and mutant fish (SI Appendix, Fig. S9D ) but with no change in p53 expression in the WKM (SI Appendix, Fig. S9E ).
Discussion
The FA genes encode proteins that function cooperatively in the Fanconi DNA-repair pathway. Here we characterized a viable vertebrate rad51 loss-of-function mutant. Loss of rad51 in zebrafish recapitulated many congenital features of FA, such as short stature and microphthalmia (1), as well as hematological defects, including marrow cytopenia and accumulation of macrocytic erythrocytes in circulation (1, 7) . Most importantly, rad51 −/− fish showed increased sensitivity to cross-linking agents, an absolute diagnostic criterion of FA (7).
Furthermore, our results show that loss of rad51 does not lead to higher sensitivity to PARP inhibitors. Previous research on mammalian cells showed that BRCA1/2 mutant cells are more sensitive to PARP inhibition. One model proposes that this is because of the importance of PARP-1 in reactivating stalled replication forks in HR-deficient cells (48) . That model is not compatible with our data, suggesting that PARP-BRCA synthetic lethality stems from functions unrelated to HR. PARP1 is highly conserved between zebrafish and humans (∼70%). A small-molecule inhibitor such as DiQ should therefore be able to enter the zebrafish embryos and inhibit the enzyme the same way as in human cells. Further evidence for this is provided by the lethality of high doses of this drug in WT and rad51 mutant fish. However, we were unable to obtain brca2 mutant zebrafish to use as a positive control for DNA damage in response to PARP inhibition. This should be taken into account when interpreting our findings.
Although loss of Rad51 leads to an early embryonic death in mice (33, 34) , zebrafish lacking rad51 survive to adulthood. This is not entirely surprising, as fish lacking brca2 also survive to adulthood (49, 50) , whereas Brca2 mutant mice die before birth (51, 52) . It has been hypothesized that maternal mRNA contributes to embryonic viability of zebrafish mutants (49) . This seems likely, considering the presence of maternally derived Rad51 in rad51 mutant embryos. However, another plausible explanation is the functional redundancy between rad51 and its paralog rad51l1 in zebrafish. Our analysis suggests that rad51 and rad51l1 are able to partially compensate for each other, leading to the lethality of double mutants. In contrast, NHEJ did not appear to play a role in compensating for the loss of HR. Interestingly, rad51 −/− fish, like brca2 −/− fish, show sex reversal that can be rescued upon p53 comutation (49, 50) . Additional p53 loss further caused development of MPNSTs in both brca2 and rad51 mutants, which occurred considerably earlier and at the higher incidence than in p53 single mutants (43, 49, 50, 53) .
FA is genetically and phenotypically heterogeneous disorder, but BM failure is the most common cause of death (1), with patients having lowered CD34
+ progenitor cell numbers from birth (10, 54) . This led to the hypothesis that hematological defects in FA originate from an impairment of HSPCs during embryonic development, which leads to a decreased number of HSPCs at birth (10, 11) . Here we provide in vivo evidence that the decrease in HSPC numbers in adult fish indeed stems from a combination of decreased proliferation and increased apoptosis during embryonic development. This defect appears to be mediated via p53 (10), as our p53/rad51 double mutants did not display any observable hematological defects in embryos or adults.
In agreement with our study, knockdown of fancd2 in zebrafish embryos causes massive apoptosis in the whole body, associated with up-regulation of genes in the p53 pathway, as well as decreased expression of cyclins. Strikingly, co-knockdown of p53 rescued both the cyclin down-regulation, as well as apoptosis (55), resembling the situation in our fish and providing further evidence for the importance of p53 signaling. This phenotype is, however, only partly consistent with what was observed in murine fetal Fancd2 −/− cells. In the murine model the reduced number of HSPCs was set off by p38-mediated reduced proliferation, without any involvement of apoptosis or p53 signaling (56). More research into the causes of the early HSPC defects and how they can be mitigated is warranted. Because of the external development and their transparency, zebrafish embryos would be an ideal tool to discover compounds that can alleviate these defects.
The decreased WKM cellularity in rad51 zebrafish mutants also mirrors defects seen in Lig4 (a protein involved in NHEJ) mutant mice, which show decreased BM cell numbers, coupled to an approximately twofold increase in proliferation of long-term HSCs (57) . This underlines the importance of repairing double-stranded breaks in HSC maintenance and suggests hyperproliferation of blood progenitors might be a common mechanism to cope with decreased cell numbers in the kidney/BM. However, like most murine FA models (58, 59) , the fish never progressed to pancytopenia or spontaneous BMF/kidney marrow failure, which is probably because of species differences in the HSC compartment, lifespan, and rearing conditions. Nevertheless, together with the clinical data (29, 30) , these facts provide further evidence for the designation of RAD51 as FANCR and show that our rad51 −/− fish are a suitable model for FA.
The progressive decline of HSC numbers in FA patients leads to BMF and there is considerable evidence for an overproduction of inflammatory cytokines in patients and mouse models (26, (60) (61) (62) (63) (64) . Furthermore, inflammatory stress (for example by repeated pI:pC injections) can induce BMF in mouse models of FA (65, 66) . We did not observe an increase in inflammatory cytokines in our unchallenged rad51 mutants, ruling out cytokine overproduction as a cause for hematological defects. We did, however, observe a 25% decrease in WKM cellularity after repeated of pI:pC injections, possibly because of decreased proliferation compared with unchallenged fish. Unlike WT fish, rad51 mutants were unable to respond appropriately to inflammation and increase monocyte production. The decrease in WKM cellularity as a result of inflammatory stress was accompanied by an up-regulation of p53, again underlining the high importance of this pathway in the etiology of FA and explaining the normalized proliferation. Interestingly, we were unable to elicit similar changes using acetaldehyde, indicating that damage induced by small aldehydes is not a major factor in FA pathogenesis, at least after birth. Our study characterized a viable vertebrate model of RAD51 loss, which recapitulates many human FA symptoms and is thus also a zebrafish model of the disease. Further study of this mutant will increase our knowledge of the cellular roles of RAD51 in vivo and will deepen our understanding of the molecular pathology of FA. Transparency of zebrafish embryos, their high fecundity, and the existence of transgenic lines labeling various blood lineages makes them very amenable for high-throughput screening in comparison with other model organisms. The application of the rad51 mutant line will significantly impact the development of novel therapeutics to improve HSPC function in FA patients, by screening for molecules that can alleviate the HSPC reduction in embryos.
Methods
Zebrafish Care and Strains. Fish lines were maintained in the Sanger Institute zebrafish facility according to European Union regulations. WT fish were of the Tübingen long-fin strain. Fish were genotyped as described previously (35) .
Western Blotting. Western blotting was carried out as described previously (67) . Antibodies can be found in SI Appendix, Table S1 .
Embryo Irradiation. Embryos were irradiated at 24 hpf in a Gammacell 1000 Elite Blood Irradiator (MDS Nordiron) at 750 cGy.
Immunostaining. Staining was carried out as described previously (68) . We used Hoechst 33342 as nuclear stain. Embryos were imaged on a Leica SP-5 confocal microscope using a 40× water-immersion lens. Antibodies can be found in SI Appendix, Table S1 .
Chromosome Spreads. Embryos were treated with 1 μg/mL DEB (Sigma Aldrich), 5 μg/mL MMC (Sigma Aldrich), 1 nM CPT (Sigma Aldrich), or 10 μM 1,5-isoquinolinediol (Sigma Aldrich) in egg water between 4 and 24 hpf. From here on we followed The Zebrafish Book, 4th edition (69), but kept the head of each embryo for genotyping. VECTASHIELD mounting medium with DAPI was used to visualize the spreads.
NHEJ Inhibition. Embryos were treated with 1, 10, 25, 50, 75, and 100 μM SCR-7 (Sigma Aldrich) at 4 hpf. Embryos were scored for defects at 24 hpf.
CRISPR-Cas9. Mutations in rad51l1 were induced at exon two, leading to a 7-bp deletion (478-484delTGGGTCC in the cDNA). The targeted DNA sequence was 5′-GGATGTCCTGTCGGTCACCCAGG-3′. ssDNA oligonucleotides 5′-TAGGATGTCC-TGTCGGTCACCC-3′ and 5′-AAACGGGTGACCGACAGGACAT-3′ (Sigma-Aldrich) were annealed and ligated with pDR274 vector (Addgene) linearized with BsaI (New England Biolabs) to make guide RNA (gRNA) expression vectors. gRNA was prepared with MAXIscript T7 kit (Life Technologies) using DraI-linearized gRNA expression vector as a template, and Cas9 mRNA was synthesized using mMESSAGE mMACHINE T7 kit (Ambion) and pMLM3613 expression vector (Addgene) linearized with PmeI (New England Biolabs). Zebrafish embryos were injected at the one-cell stage with 12.5 pg of gRNA and 160 pg of Cas9 mRNA. For a detailed zebrafish CRISPR methodology, see Brocal et al. (70) .
Histology. Formalin-fixed tissues were processed and sectioned using standard techniques (71), followed by staining with Harris H&E.
AV-PI Assay. We used the Alexa Fluor-488 Annexin V/Dead Cell Apoptosis Kit (Thermo Fisher) according to the manufacturer's instructions.
BrdU Assay on Adults. Fish were injected with 10 μL of 10 mg/mL BrdU (Sigma Aldrich) and culled at 1, 7, or 14 d postinjection. We extracted kidney and blood, made single-cell suspensions, and fixed cells in 70% EtOH overnight. BrdU immunostaining was carried out as described previously (67), after which the cells were resuspended in PBS and analyzed using FACS.
BrdU Assay on Embryos. Embryos were chilled on ice for 15 min. This was followed by a 20-min incubation in 10 mM BrdU on ice. After a 3-h recovery in egg water, embryos were fixed in 4% PFA. Heads from embryos were used for genotyping. For 2-dpf embryos, the whole tails were pooled according to genotype, whereas for 4-dpf embryos just the CHT was dissected. Samples were treated with 10 mM DTT in 1× Danieau's solution for 30 min at room temperature, followed by incubation in liberase (Roche) in PBS for 3 h at 37°C. The reaction was stopped by replacing the solution with 5% FBS/PBS. Single-cell suspensions were fixed in 70% ethanol overnight. From here on, the staining process and analysis was identical to cells obtained from adults. Antibodies can be found in SI Appendix, Table S1 .
TUNEL Assays. Embryos for TUNEL assays were fixed and stored as for ISH. Staining was carried out using the In-Situ Cell Death Detection Kit, AP (Roche), according to the manufacturer's instructions.
Kidney FACS. Dissected kidneys were placed in 5% FBS/PBS and processed to single-cell suspensions. Dead cells were excluded using DAPI (Sigma-Aldrich) or PI. Flow cytometry was carried out on a MoFlo XDP (Beckman Coulter), a BD LSRFortessa, or a BD Influx (BD Biosciences).
In Situ Hybridization. ISH was carried out as described previously (72) . We used a cmyb antisense probe. Embryos were blindly sorted into high-, medium-, and low-staining conditions followed by genotyping.
Long-Term pI:pC Injections. Fish were injected with 10 mg/mL pI:pC (SigmaAldrich) once a week, totaling four injections. Fish were culled 1 or 3 d after the last injection. Optionally, 10 mg/mL BrdU were added to the last injection. Kidneys were processed to single-cell suspensions for FACS, as described above, and cell numbers counted. Remaining cell suspensions were used for geneexpression analysis.
Long-Term Acetaldehyde Injections. For long-term acetaldehyde injections, the same protocol as for the pI:pC injections was followed, but using 10 μL 1% acetaldehyde (Sigma Aldrich) in PBS instead for the injections.
qPCRs. The qPCR reaction used SYBR green (Thermo Fisher) and run on a QuantStudio 3 (Thermo Fisher) qPCR machine. Statistics were carried out on raw ΔCt values. Primers used are listed in SI Appendix, Table S2 .
